Assessment of the Accuracy of PET/MR in Detection and Monitoring Response of Bone Metastases
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Bone Metastases
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Enrollment
- 150
- Primary Endpoint
- The investigators will report about the number of patients who preformed PET/MR for assessment of skeletal involvement as well as activity after treatment,
- Last Updated
- 6 years ago
Overview
Brief Summary
The great promise of PET/MR for assessment of skeletal metastatic involvement is derived from the extensive experience with stand- alone MR, but initial data on the use of PET/MR for assessment of bone pathology indicate that PET/MR introduces unique issues that should be addressed when determining its role in this clinical scenario.
In this study cohort includes 150 patients 18 years or older, having metastatic skeletal involvement on baseline PET/CT prior to treatment. Baseline studies and follow up studies of the patients referred post treatment, will be reviewed.
The main goal of the study is to asses the accuracy of PET/MR in detection and monitoring response of bone metastases.
Investigators
Eligibility Criteria
Inclusion Criteria
- •150 patients having metastatic skeletal involvement on baseline PET/CT prior to treatment
Exclusion Criteria
- •Pregnant or breast feeding patients.
Outcomes
Primary Outcomes
The investigators will report about the number of patients who preformed PET/MR for assessment of skeletal involvement as well as activity after treatment,
Time Frame: 1 year
and also preformed in routine PET/CT and to optimize the algorithm of MR-based attenuated PET images.